Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model
Renin angiotensin system (RAS) blockade reduces the progression of chronic kidney disease (CKD) independently of its antihypertensive effect. Ang II-induced fibrosis can be mediated by molecules such as klotho, peroxisome proliferator-activate receptor γ (PPAR-γ), and the Wnt/β-catenin pathway; howe...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-08-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2018.01033/full |
id |
doaj-68f9f77649974c2d8ae9ab856253f374 |
---|---|
record_format |
Article |
spelling |
doaj-68f9f77649974c2d8ae9ab856253f3742020-11-24T22:07:25ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2018-08-01910.3389/fphys.2018.01033369475Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy ModelEdgar MaquigussaJosne C. PaternoGabriel H. de Oliveira PokornyMariana da Silva PerezVanessa A. VarelaAntônio da Silva NovaesNestor SchorMirian A. BoimRenin angiotensin system (RAS) blockade reduces the progression of chronic kidney disease (CKD) independently of its antihypertensive effect. Ang II-induced fibrosis can be mediated by molecules such as klotho, peroxisome proliferator-activate receptor γ (PPAR-γ), and the Wnt/β-catenin pathway; however, the interaction among these molecules and RAS activation is not completely known. The aim of this study was to investigate a possible link between RAS, PPAR-γ, and Klotho in the 5/6 nephrectomy (NX) animals. NX rats presented hypertension that was blunted by both losartan and propranolol, however, only losartan was able to reduce the expression levels of fibronectin FSP1 and TGF-β in the remnant kidney. The anti-fibrotic Klotho and PPAR-γ were reduced in the remnant kidney, and losartan, but not propranolol, restored their levels. In contrast, the profibrotic Wnt 7a and Wnt 3 were upregulated and losartan prevented the increase in Wnts. In vitro, Ang II induced a decrease in both klotho and in PPAR-γ in Madin-Darby canine kidney (MDCK) cells, and this effect was blunted by losartan. However, klotho expression was increased by pioglitazone, an agonist of PPAR-γ, and suppressed by BADGE, an antagonist of PPAR-γ, suggesting that the effect of Ang II downregulating klotho is mediated by PPAR-γ. These data suggest that activation of the Wnt pathway together with downregulation of PPAR-γ that in turn suppresses klotho contribute to potentiating the profibrotic effect of Ang II.https://www.frontiersin.org/article/10.3389/fphys.2018.01033/fullklothoangiotensin IIPPAR-γchronic kidney diseasehypertension |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Edgar Maquigussa Josne C. Paterno Gabriel H. de Oliveira Pokorny Mariana da Silva Perez Vanessa A. Varela Antônio da Silva Novaes Nestor Schor Mirian A. Boim |
spellingShingle |
Edgar Maquigussa Josne C. Paterno Gabriel H. de Oliveira Pokorny Mariana da Silva Perez Vanessa A. Varela Antônio da Silva Novaes Nestor Schor Mirian A. Boim Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model Frontiers in Physiology klotho angiotensin II PPAR-γ chronic kidney disease hypertension |
author_facet |
Edgar Maquigussa Josne C. Paterno Gabriel H. de Oliveira Pokorny Mariana da Silva Perez Vanessa A. Varela Antônio da Silva Novaes Nestor Schor Mirian A. Boim |
author_sort |
Edgar Maquigussa |
title |
Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model |
title_short |
Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model |
title_full |
Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model |
title_fullStr |
Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model |
title_full_unstemmed |
Klotho and PPAR Gamma Activation Mediate the Renoprotective Effect of Losartan in the 5/6 Nephrectomy Model |
title_sort |
klotho and ppar gamma activation mediate the renoprotective effect of losartan in the 5/6 nephrectomy model |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Physiology |
issn |
1664-042X |
publishDate |
2018-08-01 |
description |
Renin angiotensin system (RAS) blockade reduces the progression of chronic kidney disease (CKD) independently of its antihypertensive effect. Ang II-induced fibrosis can be mediated by molecules such as klotho, peroxisome proliferator-activate receptor γ (PPAR-γ), and the Wnt/β-catenin pathway; however, the interaction among these molecules and RAS activation is not completely known. The aim of this study was to investigate a possible link between RAS, PPAR-γ, and Klotho in the 5/6 nephrectomy (NX) animals. NX rats presented hypertension that was blunted by both losartan and propranolol, however, only losartan was able to reduce the expression levels of fibronectin FSP1 and TGF-β in the remnant kidney. The anti-fibrotic Klotho and PPAR-γ were reduced in the remnant kidney, and losartan, but not propranolol, restored their levels. In contrast, the profibrotic Wnt 7a and Wnt 3 were upregulated and losartan prevented the increase in Wnts. In vitro, Ang II induced a decrease in both klotho and in PPAR-γ in Madin-Darby canine kidney (MDCK) cells, and this effect was blunted by losartan. However, klotho expression was increased by pioglitazone, an agonist of PPAR-γ, and suppressed by BADGE, an antagonist of PPAR-γ, suggesting that the effect of Ang II downregulating klotho is mediated by PPAR-γ. These data suggest that activation of the Wnt pathway together with downregulation of PPAR-γ that in turn suppresses klotho contribute to potentiating the profibrotic effect of Ang II. |
topic |
klotho angiotensin II PPAR-γ chronic kidney disease hypertension |
url |
https://www.frontiersin.org/article/10.3389/fphys.2018.01033/full |
work_keys_str_mv |
AT edgarmaquigussa klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel AT josnecpaterno klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel AT gabrielhdeoliveirapokorny klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel AT marianadasilvaperez klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel AT vanessaavarela klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel AT antoniodasilvanovaes klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel AT nestorschor klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel AT mirianaboim klothoandppargammaactivationmediatetherenoprotectiveeffectoflosartaninthe56nephrectomymodel |
_version_ |
1725820551773028352 |